Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
复制标题
DOI：
10.1016/j.kint.2018.10.018
复制
发表时间：
2019-02-01
影响因子：
19.6
通讯作者：
Wenderfer, Scott E.
中科院分区：
文献类型：
--
作者：
Floege, Juergen;Barbour, Sean J.;Wenderfer, Scott E.
肾脏疾病：改善全球结局（KDIGO）倡议于2017年11月组织了一次关于肾小球疾病的争议会议。会议重点讨论了2012年KDIGO指南，目的是确定自指南出版以来对术语、发病机制、诊断工作的新见解，特别是肾小球疾病的治疗。该小组一致认为，大多数指南建议，特别是那些涉及治疗的建议，需要由指南更新工作组重新审查。本报告涵盖肾小球疾病、伊加肾病和膜性肾病的一般管理。
The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline's publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.